 | • レポートコード：MRC2312MG15123 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、67ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の動物用ペプチド製品市場規模と予測を収録しています。・世界の動物用ペプチド製品市場：売上、2018年-2023年、2024年-2029年 ・世界の動物用ペプチド製品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の動物用ペプチド製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「オキシトシン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 動物用ペプチド製品のグローバル主要企業は、AmbioPharm、 Zoetis、 Ceva Corporate、 Huvepharma、 Lifecome Biochemistry、 Qilu Pharmaceutical、 Orion Animal Nutrition、 Vega Pharma、 Tianjin Xinxing Veterinary Pharmaceutical、 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、動物用ペプチド製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の動物用ペプチド製品市場：タイプ別、2018年-2023年、2024年-2029年 世界の動物用ペプチド製品市場：タイプ別市場シェア、2022年 ・オキシトシン、ゴナドレリン、ブセレリン、動物用バシトラシン亜鉛、その他 世界の動物用ペプチド製品市場：用途別、2018年-2023年、2024年-2029年 世界の動物用ペプチド製品市場：用途別市場シェア、2022年 ・豚、牛、羊、その他 世界の動物用ペプチド製品市場：地域・国別、2018年-2023年、2024年-2029年 世界の動物用ペプチド製品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における動物用ペプチド製品のグローバル売上、2018年-2023年 ・主要企業における動物用ペプチド製品のグローバル売上シェア、2022年 ・主要企業における動物用ペプチド製品のグローバル販売量、2018年-2023年 ・主要企業における動物用ペプチド製品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 AmbioPharm、 Zoetis、 Ceva Corporate、 Huvepharma、 Lifecome Biochemistry、 Qilu Pharmaceutical、 Orion Animal Nutrition、 Vega Pharma、 Tianjin Xinxing Veterinary Pharmaceutical、 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. ************************************************************* ・調査・分析レポートの概要 動物用ペプチド製品市場の定義 市場セグメント 世界の動物用ペプチド製品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の動物用ペプチド製品市場規模 世界の動物用ペプチド製品市場規模：2022年 VS 2029年 世界の動物用ペプチド製品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの動物用ペプチド製品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の動物用ペプチド製品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：オキシトシン、ゴナドレリン、ブセレリン、動物用バシトラシン亜鉛、その他 動物用ペプチド製品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：豚、牛、羊、その他 動物用ペプチド製品の用途別グローバル売上・予測 ・地域別市場分析 地域別動物用ペプチド製品市場規模 2022年と2029年 地域別動物用ペプチド製品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） AmbioPharm、 Zoetis、 Ceva Corporate、 Huvepharma、 Lifecome Biochemistry、 Qilu Pharmaceutical、 Orion Animal Nutrition、 Vega Pharma、 Tianjin Xinxing Veterinary Pharmaceutical、 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. ... |
This research report provides a comprehensive analysis of the Veterinary Peptide Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Veterinary Peptide Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Veterinary Peptide Products, challenges faced by the industry, and potential opportunities for market players.
The global Veterinary Peptide Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Veterinary Peptide Products market presents opportunities for various stakeholders, including Pig, Ox. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Veterinary Peptide Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Veterinary Peptide Products market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Veterinary Peptide Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Veterinary Peptide Products market.
Market Overview: The report provides a comprehensive overview of the Veterinary Peptide Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Oxytocin, Gonadorelin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Veterinary Peptide Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Veterinary Peptide Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Veterinary Peptide Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Veterinary Peptide Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Veterinary Peptide Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Veterinary Peptide Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Veterinary Peptide Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Veterinary Peptide Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Veterinary Peptide Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oxytocin
Gonadorelin
Buserelin
Veterinary Bacitracin Zinc
Others
Market segment by Application
Pig
Ox
Sheep
Others
Global Veterinary Peptide Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
AmbioPharm
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Peptide Products, market overview.
Chapter 2: Global Veterinary Peptide Products market size in revenue.
Chapter 3: Detailed analysis of Veterinary Peptide Products company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Peptide Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Veterinary Peptide Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Peptide Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Peptide Products Overall Market Size
2.1 Global Veterinary Peptide Products Market Size: 2022 VS 2029
2.2 Global Veterinary Peptide Products Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Veterinary Peptide Products Players in Global Market
3.2 Top Global Veterinary Peptide Products Companies Ranked by Revenue
3.3 Global Veterinary Peptide Products Revenue by Companies
3.4 Top 3 and Top 5 Veterinary Peptide Products Companies in Global Market, by Revenue in 2022
3.5 Global Companies Veterinary Peptide Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Veterinary Peptide Products Players in Global Market
3.6.1 List of Global Tier 1 Veterinary Peptide Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Veterinary Peptide Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Peptide Products Market Size Markets, 2022 & 2029
4.1.2 Oxytocin
4.1.3 Gonadorelin
4.1.4 Buserelin
4.1.5 Veterinary Bacitracin Zinc
4.1.6 Others
4.2 By Type – Global Veterinary Peptide Products Revenue & Forecasts
4.2.1 By Type – Global Veterinary Peptide Products Revenue, 2018-2023
4.2.2 By Type – Global Veterinary Peptide Products Revenue, 2024-2029
4.2.3 By Type – Global Veterinary Peptide Products Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Veterinary Peptide Products Market Size, 2022 & 2029
5.1.2 Pig
5.1.3 Ox
5.1.4 Sheep
5.1.5 Others
5.2 By Application – Global Veterinary Peptide Products Revenue & Forecasts
5.2.1 By Application – Global Veterinary Peptide Products Revenue, 2018-2023
5.2.2 By Application – Global Veterinary Peptide Products Revenue, 2024-2029
5.2.3 By Application – Global Veterinary Peptide Products Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Veterinary Peptide Products Market Size, 2022 & 2029
6.2 By Region – Global Veterinary Peptide Products Revenue & Forecasts
6.2.1 By Region – Global Veterinary Peptide Products Revenue, 2018-2023
6.2.2 By Region – Global Veterinary Peptide Products Revenue, 2024-2029
6.2.3 By Region – Global Veterinary Peptide Products Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Veterinary Peptide Products Revenue, 2018-2029
6.3.2 US Veterinary Peptide Products Market Size, 2018-2029
6.3.3 Canada Veterinary Peptide Products Market Size, 2018-2029
6.3.4 Mexico Veterinary Peptide Products Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Veterinary Peptide Products Revenue, 2018-2029
6.4.2 Germany Veterinary Peptide Products Market Size, 2018-2029
6.4.3 France Veterinary Peptide Products Market Size, 2018-2029
6.4.4 U.K. Veterinary Peptide Products Market Size, 2018-2029
6.4.5 Italy Veterinary Peptide Products Market Size, 2018-2029
6.4.6 Russia Veterinary Peptide Products Market Size, 2018-2029
6.4.7 Nordic Countries Veterinary Peptide Products Market Size, 2018-2029
6.4.8 Benelux Veterinary Peptide Products Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Veterinary Peptide Products Revenue, 2018-2029
6.5.2 China Veterinary Peptide Products Market Size, 2018-2029
6.5.3 Japan Veterinary Peptide Products Market Size, 2018-2029
6.5.4 South Korea Veterinary Peptide Products Market Size, 2018-2029
6.5.5 Southeast Asia Veterinary Peptide Products Market Size, 2018-2029
6.5.6 India Veterinary Peptide Products Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Veterinary Peptide Products Revenue, 2018-2029
6.6.2 Brazil Veterinary Peptide Products Market Size, 2018-2029
6.6.3 Argentina Veterinary Peptide Products Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Veterinary Peptide Products Revenue, 2018-2029
6.7.2 Turkey Veterinary Peptide Products Market Size, 2018-2029
6.7.3 Israel Veterinary Peptide Products Market Size, 2018-2029
6.7.4 Saudi Arabia Veterinary Peptide Products Market Size, 2018-2029
6.7.5 UAE Veterinary Peptide Products Market Size, 2018-2029
7 Veterinary Peptide Products Companies Profiles
7.1 AmbioPharm
7.1.1 AmbioPharm Company Summary
7.1.2 AmbioPharm Business Overview
7.1.3 AmbioPharm Veterinary Peptide Products Major Product Offerings
7.1.4 AmbioPharm Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.1.5 AmbioPharm Key News & Latest Developments
7.2 Zoetis
7.2.1 Zoetis Company Summary
7.2.2 Zoetis Business Overview
7.2.3 Zoetis Veterinary Peptide Products Major Product Offerings
7.2.4 Zoetis Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.2.5 Zoetis Key News & Latest Developments
7.3 Ceva Corporate
7.3.1 Ceva Corporate Company Summary
7.3.2 Ceva Corporate Business Overview
7.3.3 Ceva Corporate Veterinary Peptide Products Major Product Offerings
7.3.4 Ceva Corporate Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.3.5 Ceva Corporate Key News & Latest Developments
7.4 Huvepharma
7.4.1 Huvepharma Company Summary
7.4.2 Huvepharma Business Overview
7.4.3 Huvepharma Veterinary Peptide Products Major Product Offerings
7.4.4 Huvepharma Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.4.5 Huvepharma Key News & Latest Developments
7.5 Lifecome Biochemistry
7.5.1 Lifecome Biochemistry Company Summary
7.5.2 Lifecome Biochemistry Business Overview
7.5.3 Lifecome Biochemistry Veterinary Peptide Products Major Product Offerings
7.5.4 Lifecome Biochemistry Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.5.5 Lifecome Biochemistry Key News & Latest Developments
7.6 Qilu Pharmaceutical
7.6.1 Qilu Pharmaceutical Company Summary
7.6.2 Qilu Pharmaceutical Business Overview
7.6.3 Qilu Pharmaceutical Veterinary Peptide Products Major Product Offerings
7.6.4 Qilu Pharmaceutical Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.6.5 Qilu Pharmaceutical Key News & Latest Developments
7.7 Orion Animal Nutrition
7.7.1 Orion Animal Nutrition Company Summary
7.7.2 Orion Animal Nutrition Business Overview
7.7.3 Orion Animal Nutrition Veterinary Peptide Products Major Product Offerings
7.7.4 Orion Animal Nutrition Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.7.5 Orion Animal Nutrition Key News & Latest Developments
7.8 Vega Pharma
7.8.1 Vega Pharma Company Summary
7.8.2 Vega Pharma Business Overview
7.8.3 Vega Pharma Veterinary Peptide Products Major Product Offerings
7.8.4 Vega Pharma Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.8.5 Vega Pharma Key News & Latest Developments
7.9 Tianjin Xinxing Veterinary Pharmaceutical
7.9.1 Tianjin Xinxing Veterinary Pharmaceutical Company Summary
7.9.2 Tianjin Xinxing Veterinary Pharmaceutical Business Overview
7.9.3 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Major Product Offerings
7.9.4 Tianjin Xinxing Veterinary Pharmaceutical Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.9.5 Tianjin Xinxing Veterinary Pharmaceutical Key News & Latest Developments
7.10 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
7.10.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Company Summary
7.10.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
7.10.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Major Product Offerings
7.10.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Veterinary Peptide Products Revenue in Global Market (2018-2023)
7.10.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer